Rigel Pharmaceuticals Inc...

NASDAQ: RIGL · Real-Time Price · USD
39.55
1.66 (4.38%)
At close: Aug 15, 2025, 3:59 PM
39.51
-0.10%
After-hours: Aug 15, 2025, 07:58 PM EDT

Rigel Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
17.48M -25.09M -58.57M -17.91M
Depreciation & Amortization
2.23M 1.24M 998K 1.16M
Stock-Based Compensation
12.39M 8.81M 12.38M 9.49M
Other Working Capital
14.26M -1.06M -5.61M 14.05M
Other Non-Cash Items
-788K -213K 481K 3.14M
Deferred Income Tax
n/a n/a n/a 287K
Change in Working Capital
153K 9.52M -29.05M 9.72M
Operating Cash Flow
31.47M -5.74M -73.76M 5.88M
Capital Expenditures
-36K -15M -450K -627K
Cash Acquisitions
n/a n/a 893K 627K
Purchase of Investments
-35.27M -31.21M -28.89M -141.46M
Sales Maturities Of Investments
39.7M 41.65M 101.23M 62.05M
Other Investing Acitivies
98K 259K 73.23M -627K
Investing Cash Flow
4.13M -4.3M 72.78M -80.04M
Debt Repayment
n/a 19.95M 4.43M n/a
Common Stock Repurchased
-10M n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-1.64M -1.58M 2.12M 62.67M
Financial Cash Flow
-11.64M 18.37M 6.55M 62.67M
Net Cash Flow
23.96M 8.33M 5.57M -11.48M
Free Cash Flow
31.43M -20.74M -74.21M 5.25M